Ashton Tweed Connection Vol. 2 No. 1

Share

 

Ashton Tweed logo

Ashton Tweed Connection

Volume 2, Number 3

Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.
Stay Connected: Special Targeted News

 

Go beyond the news… Get more focused information about your industry and hiring trends. Click now to enhance your subscription.

Stay Connected: Special Targeted News

Interim CMO Case Study
Interim CMO Aids in Transition
A pharmaceutical company being acquired by two larger companies in quick succession lost a critical member of their due-diligence team. During the integration process, permanent hiring was put on hold.A strong interim CMO through Ashton Tweed was the answer.
Read more: Interim CMO Aids in Transition

Read more

Ashton Tweed's 10 Year Anniversary video
10-Year Leader in Life Sciences
This year, Ashton Tweed celebrates ten years of service to the life sciences industry. Learn how our expertise has been built and benefits your organization and life sciences candidates.
Ashton Tweed's 10 Year Anniversary video

WATCH THE VIDEO

Ashton Tweed webcast series

Do you have questions about life sciences opportunities or talent? Tune in to an Ashton Tweed webcast.

Previous webcasts
Taking Action in Your Career Advancement, How to Stand Out in a Competitive Job Market, and How to Nail an Interview.

Tell us what you would like to learn about in upcoming webcasts. Click to send your request.

Read more

Featured Pros

We feature exceptional candidates waiting to be matched with life science opportunities.

Read more

Read more

Read more

Featured Jobs

We feature our difficult-to-fill senior-level openings that are open to qualified candidates.

Read more

Read more

Read more

Upcoming Events

Never miss a life sciences networking event with our up-to-date events calendar.

Read more

Read more

2015 Biotechnology Hiring Trends

2015 Biotechnology Hiring Trends
A recent Credit Suisse report titled, Global Biotechnology — An Outlook for 2015, is robust with data about future trends in the biotech industry. The report concludes that biotech can still outperform the general market due in part to the critical shift in large cap biotech’s business model.
Read more

READ MORE

Leaner Sales Forces
Leaner Sales Forces
The pharmaceutical industry is now depending upon leaner sales forces due to industry mergers, the expiration of blockbuster drug patents, and a shift toward flexible, regional, specialized sales teams.
Read more

Read more…

Thanks to the Managers
Thanks to the Managers
Successful managers have verifiable track records for leading and managing successful teams. The better a manager is on the job, the more elevated the team performance and productivity.
Read more

Read more…

The American Idol Approach
The American Idol Approach
Pfizer has a fresh way of hiring its Swedish employees. Last spring Pfizer had six job openings and 200 applicants. The company took the novel approach of looking solely at how applicants interacted.
Read more

Read more…

Weinberg, Interim CEO
Weinberg, Interim CEO
Earlier this year, Sanofi terminated former CEO Chris Viehbacher. Since his ouster, the industry has been waiting to see who will be named his replacement. Serge Weinberg is acting interim CEO and chair of the company during this time.
Read more

Read more…

Havel: Express Scripts' Interim CEO

Havel: Express Scripts’ Interim CEO
Express Scripts has announced that CFO Cathy Smith will leave the company. She will be replaced by James Havel, CFO of Major Brands Holdings, on an interim basis, starting January 2, 2015. The company said that Smith was leaving to “pursue other interests,” but it appears she was unable to get along with CEO George Paz.
Read more

READ MORE…

Tecomet Acquires OEM Solutions

Genstar Capital portfolio firm, Tecomet, has acquired Symmetry Medical’s original equipment manufacturing (OEM) solutions business for $450m. OEM Solutions has 2,300 employees, 450 customers, and operates 13 facilities in the UK, US, Ireland, France, and Malaysia.
Read more

READ MORE

Alnylam Pharmaceuticals’ Strategy

Alnylam Pharmaceuticals announced its new pipeline growth strategy, which will be split into three units. The new strategy will focus on development and commercialization of RNAi therapeutics in three Strategic Therapeutic Areas (STArs)
Read more: Survey: Managing Innovation in Pharmaceuticals

READ MORE

Share

Comments are closed.